Boehringer, Eli Lilly reveal post-hoc results for linagliptin

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, which explored the clinical effect of linagliptin on albuminuria in pati...Read more

Bayer recognizes innovation by Korean start-up

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is recognized and acknowledged by Bayer as the final winners of its Grant...Read more

Aquavit, Green Cross sign MoU

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) with US-based Aquavit Pharmaceuticals for strategic collaboration sur...Read more

Chugai gets Japanese nod cancer drug Kadcyla

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Chugai Pharmaceutical's anti-cancer agent Kadcyla, for HER2-positive in...Read more

Nexavar seeks marketing authorization in Japan

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Health, Labour and Welfare (MHLW) in Japan for Nexavar (Sorafenib) tablets...Read more

Starpharma to receive $6 mn for overseas R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities related to VivaGel. Starpharma has made...Read more

Thermo Fisher Scientific celebrates 20th year in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the milestone on August 30, 2016 at Block 33, Marsiling Industrial Estate ...Read more

FDA to review Vanda blindness drug Tasimelteon

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-...Read more

Novartis' Jakavi improves myelofibrosis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustained reductions in spleen size, a hallmark of myelofibrosis, while als...Read more

Quest signs $2mn development deal with Korean firm

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cancer, entered into a long term strategic relationship with AD Biotech, a...Read more

EU approves Novartis' Bexsero for meningitis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2013

Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) for use in individuals from two months of age and older. "This men...Read more

Material science firm Crystal to open lab in China

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials science development service packages in drug R&D. Crystal has adopte...Read more

ShangPharma celebrates 10 years with Eli Lilly

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, celebrated the 10th anniversary of its partnership with Eli Lilly. "I a...Read more

Google, Facebook, Apple invite nominations for 2014 'Breakthrough Prize'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

Singapore: Breakthrough Prize in Life Sciences Foundation has opened its process of online nomination for the 2014 prizes. The nominations could be made using the website www.breakthroughpr...Read more

Bionomics cancer trial shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its cancer drug candidate BNC105 in women with ovarian cancer. After com...Read more

New drug slows cancer significantly

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dramatic and rapid effects on prostate cancer, which had already spread...Read more

Shionogi launches London headquarter

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be called Shionogi Limited. The new headquarters will form a new era for ...Read more

Tetraphase antibiotic gets FDA QIDP designation

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candidate, eravacycline, as a Qualified Infectious Disease Product (QIDP).QI...Read more